1. PRODUCT OVERVIEW
1.1. MARKET DEFINITION
1.2. SCOPE OF THE MARKET
1.2.1. MARKETS COVERED
1.2.2. YEARS CONSIDERED FOR STUDY
1.2.3. KEY MARKET SEGMENTATIONS
2. RESEARCH METHODOLOGY
2.1. OBJECTIVE OF THE STUDY
2.2. BASELINE METHODOLOGY
2.3. KEY INDUSTRY PARTNERS
2.4. MAJOR ASSOCIATION AND SECONDARY SOURCES
2.5. FORECASTING METHODOLOGY
2.6. DATA TRIANGULATION & VALIDATION
2.7. ASSUMPTIONS AND LIMITATIONS
3. EXECUTIVE SUMMARY
3.1. OVERVIEW OF THE MARKET
3.2. OVERVIEW OF KEY MARKET SEGMENTATIONS
3.3. OVERVIEW OF KEY MARKET PLAYERS
3.4. OVERVIEW OF KEY REGIONS/COUNTRIES
3.5. OVERVIEW OF MARKET DRIVERS, CHALLENGES, TRENDS
4. VOICE OF CUSTOMER
5. JAPAN RABIES VACCINE MARKET OUTLOOK
5.1. MARKET SIZE & FORECAST
5.1.1. BY VALUE
5.2. MARKET SHARE & FORECAST
5.2.1. BY PRODUCT TYPE (CHICK EMBRYO CELLS RABIES VACCINE, VERO CELL RABIES VACCINE, HUMAN DIPLOID CELL VACCINE, OTHERS)
5.2.2. BY APPLICATION (HUMAN, ANIMAL)
5.2.3. BY END USER (HOSPITALS, VETERINARY CLINICS, OTHERS)
5.2.4. BY REGION
5.2.5. BY COMPANY (2024)
5.3. MARKET MAP
6. HOKKAIDO RABIES VACCINE MARKET OUTLOOK
6.1. MARKET SIZE & FORECAST
6.1.1. BY VALUE
6.2. MARKET SHARE & FORECAST
6.2.1. BY PRODUCT TYPE
6.2.2. BY APPLICATION
6.2.3. BY END USER
7. TOHOKU RABIES VACCINE MARKET OUTLOOK
7.1. MARKET SIZE & FORECAST
7.1.1. BY VALUE
7.2. MARKET SHARE & FORECAST
7.2.1. BY PRODUCT TYPE
7.2.2. BY APPLICATION
7.2.3. BY END USER
8. KANTO RABIES VACCINE MARKET OUTLOOK
8.1. MARKET SIZE & FORECAST
8.1.1. BY VALUE
8.2. MARKET SHARE & FORECAST
8.2.1. BY PRODUCT TYPE
8.2.2. BY APPLICATION
8.2.3. BY END USER
9. CHUBU RABIES VACCINE MARKET OUTLOOK
9.1. MARKET SIZE & FORECAST
9.1.1. BY VALUE
9.2. MARKET SHARE & FORECAST
9.2.1. BY PRODUCT TYPE
9.2.2. BY APPLICATION
9.2.3. BY END USER
10. KANSAI RABIES VACCINE MARKET OUTLOOK
10.1. MARKET SIZE & FORECAST
10.1.1. BY VALUE
10.2. MARKET SHARE & FORECAST
10.2.1. BY PRODUCT TYPE
10.2.2. BY APPLICATION
10.2.3. BY END USER
11. CHUGOKU RABIES VACCINE MARKET OUTLOOK
11.1. MARKET SIZE & FORECAST
11.1.1. BY VALUE
11.2. MARKET SHARE & FORECAST
11.2.1. BY PRODUCT TYPE
11.2.2. BY APPLICATION
11.2.3. BY END USER
12. SHIKOKU RABIES VACCINE MARKET OUTLOOK
12.1. MARKET SIZE & FORECAST
12.1.1. BY VALUE
12.2. MARKET SHARE & FORECAST
12.2.1. BY PRODUCT TYPE
12.2.2. BY APPLICATION
12.2.3. BY END USER
13. KYUSHU RABIES VACCINE MARKET OUTLOOK
13.1. MARKET SIZE & FORECAST
13.1.1. BY VALUE
13.2. MARKET SHARE & FORECAST
13.2.1. BY PRODUCT TYPE
13.2.2. BY APPLICATION
13.2.3. BY END USER
14. MARKET DYNAMICS
14.1. DRIVERS
14.2. CHALLENGES
15. MARKET TRENDS & DEVELOPMENTS
15.1. RECENT DEVELOPMENTS
15.2. PRODUCT LAUNCHES
15.3. MERGERS & ACQUISITIONS
16. JAPAN RABIES VACCINE MARKET: SWOT ANALYSIS
17. COMPETITIVE LANDSCAPE
17.1. BHARAT BIOTECH INTERNATIONAL LIMITED
17.1.1. BUSINESS OVERVIEW
17.1.2. PRODUCT & SERVICE OFFERINGS
17.1.3. RECENT DEVELOPMENTS
17.1.4. KEY PERSONNEL
17.1.5. FINANCIALS (IF LISTED)
17.1.6. SWOT ANALYSIS
17.2. VIRBAC S.A.
17.3. SANOFI
17.4. BOEHRINGER INGELHEIM INTERNATIONAL GMBH.
17.5. NOVARTIS AG
17.6. CADILA PHARMACEUTICALS LIMITED
17.7. ELANCO ANIMAL HEALTH INCORPORATED
17.8. MERCK & CO., INC
17.9. ZOETIS JAPAN CO., LTD
18. STRATEGIC RECOMMENDATIONS
19. ABOUT US & DISCLAIMER
著作権 ©2022 無断複写・転載を禁じます
